In the Press

iPathwayGuide’s prediction for a COVID-19 drug validated in clinical study

By |2020-08-26T15:49:23-04:00April 28, 2020|Updates, In the Press, iPathwayGuide|

Methylprednisolone effective in treating critically ill patients Recently, we announced that Advaita’s advanced AI platform, iPathwayGuide, was able to predict an existing drug with clinical efficacy against COVID-19. While the manuscript undergoes peer review, a preprint is available from Nature Research. Read [...]

Advaita’s iPathwayGuide provides a cost-effective alternative to Ingenuity Pathway Analysis (IPA) on Yet Another Continent

By |2020-08-26T15:57:49-04:00October 14, 2019|Updates, In the Press, iPathwayGuide, iVariantGuide|

Inqaba Biotechnical Industries partners with Advaita Bioinformatics to provide advanced pathway analysis software in Sub-Saharan Africa ANN ARBOR, MI – October 14, 2019— Advaita Bioinformatics, the leader in the interpretation of high-throughput biomedical data, today announced a new distribution partnership [...]

SCIEX Announces OneOmics Collaborators

By |2020-08-26T16:13:37-04:00March 16, 2015|Updates, In the Press|

SCIEX a global leader in life science analytical technologies today announced collaborators in the OneOmics™ project an exclusive partnership between Illumina and SCIEX that integrates SWATH™ Acquisition based next-generation proteomics (NGP) and next-generation sequencing (NGS) data on the BaseSpace® cloud [...]

Advaita Secures $1.76M Phase II Award

By |2020-08-26T16:15:26-04:00April 18, 2014|Updates, In the Press|

Today, Advaita Bioinformatics received a Notice of Award from the National Institutes of Health’s (NIH) National Institute of General Medical Sciences (NIGMS) for a Phase II Small Business Investigational Research (SBIR) grant worth $1.76M over three years. Advaita is a [...]

Go to Top